Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
Status:
Completed
Trial end date:
2021-03-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of gastric pH changes due to
famotidine administration on the drug levels of prototype BMS-986256 tablet formulation in
healthy participants.